Login / Signup
Morten J Lee
(Morten Lee)
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 5
Top Topics
Small Cell Lung Cancer
Lymph Node Metastasis
Randomized Controlled Trial
Helicobacter Pylori
Top Venues
Science advances
ACS nano
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xiaomin Jiang
,
Taokun Luo
,
Kaiting Yang
,
Morten J Lee
,
Jing Liu
,
Langston Tillman
,
Wenyao Zhen
,
Ralph R Weichselbaum
,
Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition.
Science advances
10 (29) (2024)
Xiaomin Jiang
,
Taokun Luo
,
Kaiting Yang
,
Morten J Lee
,
Jing Liu
,
Langston Tillman
,
Wenyao Zhen
,
Ralph R Weichselbaum
,
Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition.
Science advances
10 (29) (2024)
Xiaomin Jiang
,
Taokun Luo
,
Kaiting Yang
,
Morten J Lee
,
Jing Liu
,
Langston Tillman
,
Wenyao Zhen
,
Ralph R Weichselbaum
,
Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition.
Science advances
10 (29) (2024)
Xiaomin Jiang
,
Taokun Luo
,
Kaiting Yang
,
Morten J Lee
,
Jing Liu
,
Langston Tillman
,
Wenyao Zhen
,
Ralph R Weichselbaum
,
Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition.
Science advances
10 (29) (2024)
Xiaomin Jiang
,
Morten J Lee
,
Junjie Xia
,
Taokun Luo
,
Jianqiao Liu
,
Megan Rodriguez
,
Wenbin Lin
Two-Stage SN38 Release from a Core-Shell Nanoparticle Enhances Tumor Deposition and Antitumor Efficacy for Synergistic Combination with Immune Checkpoint Blockade.
ACS nano
(2022)